← Leaderboards
Guillem Pratx
Stanford University
$5,556,207
Attributed
$8,356,909
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,356,909 · 9
By mechanism
R01$5,713,054 · 3
R21$1,745,830 · 4
R61$639,127 · 1
R43$258,898 · 1
Top collaborators
- Mathieu Spriet4 shared
- Todd Sulchek4 shared
- John B Sunwoo3 shared
- Yunzhi Yang3 shared
- Stuart R Miller1 shared
Most similar at Stanford University
Same institution · by research overlap
- Robert Sinclair$1,709,201
- Maarten G Lansberg$12,308,726
- Shan X. Wang$16,205,138
- John B Sunwoo$14,810,025
- Yunzhi Yang$11,928,757
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsIn VivoImageMolecularIn VitroTumorSamplingResolutionUptakeTechnologyRadiotracerMeasurementDesignRadioisotopesRadiolabeledMalignant NeoplasmsPositron-Emission TomographyPropertyClinical ResearchLabelImaging DeviceMicroscopyImaging ModalityTrafficking
Grant awards (24)
Preclinical microphysiological tumor models for nuclear medicine$514,734
R01 · FY2025 · CA · contact PI
A Novel Assay to Individualize Resensitization of Iodine-Refractory Thyroid Cancer$216,546
R61 · FY2025 · CA · contact PI
New tools for tracking single cells in vivo$589,925
R01 · FY2024 · EB · contact PI
Preclinical microphysiological tumor models for nuclear medicine$513,249
R01 · FY2024 · CA · contact PI
Investigation of nanobubble nucleation by radiation therapy$231,600
R21 · FY2024 · EB · contact PI
A Novel Assay to Individualize Resensitization of Iodine-Refractory Thyroid Cancer$205,719
R61 · FY2024 · CA · contact PI
New tools for tracking single cells in vivo$588,962
R01 · FY2023 · EB · contact PI
Preclinical microphysiological tumor models for nuclear medicine$529,906
R01 · FY2023 · CA · contact PI
A Novel Assay to Individualize Resensitization of Iodine-Refractory Thyroid Cancer$216,862
R61 · FY2023 · CA · contact PI
Investigation of nanobubble nucleation by radiation therapy$193,281
R21 · FY2023 · EB · contact PI
Tumor-targeted delivery and cell internalization of theranostic gadolinium nanoparticles for image-guided nanoparticle-enhanced radiation therapy$181,122
R21 · FY2022 · EB · contact PI
New tools for tracking single cells in vivo$620,088
R01 · FY2021 · EB · contact PI
Directional sensor for radioluminescence microscopy of next-generation tumor models$258,898
R43 · FY2021 · CA
New tools for tracking single cells in vivo$650,016
R01 · FY2020 · EB · contact PI
Quantitative Imaging of Cancer Drug Resistance via Radioluminescence Microarrays$333,421
R01 · FY2018 · CA · contact PI
Quantitative Imaging of Cancer Drug Resistance via Radioluminescence Microarrays$333,398
R01 · FY2017 · CA · contact PI
High-throughput radionuclide counting and sorting of single cells$209,453
R21 · FY2017 · CA · contact PI
Quantitative Imaging of Cancer Drug Resistance via Radioluminescence Microarrays$333,038
R01 · FY2016 · CA · contact PI
High-throughput radionuclide counting and sorting of single cells$244,361
R21 · FY2016 · CA · contact PI
Quantitative Imaging of Cancer Drug Resistance via Radioluminescence Microarrays$343,181
R01 · FY2015 · CA · contact PI
High-throughput radionuclide counting and sorting of single cells$244,361
R21 · FY2015 · CA · contact PI
Real-time tracking of single cells in live animals$240,893
R21 · FY2015 · HL · contact PI
Quantitative Imaging of Cancer Drug Resistance via Radioluminescence Microarrays$363,136
R01 · FY2014 · CA · contact PI
Real-time tracking of single cells in live animals$200,759
R21 · FY2014 · HL · contact PI